Quality medicines targeting a greater part of societal burden of disease continue to be unaffordable to most African countries and populations.
We partner to create shared value and maximise our impact.
- Creating shared value.
- Reducing inefficiencies.
- Balancing cost and quality.
- Creating economies of scale.
- Strengthening existing infrastructure.
- Operating sustainably.
- Being socially responsible.
- Achieving clear measurable results.
- Being accountable and independent.
- Evaluating our impact.